Lv4
710 积分 2021-05-17 加入
EZH2: a novel target for cancer treatment
3年前
已完结
Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3年前
已完结
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3年前
已完结
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model
3年前
已完结
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
3年前
已完结
The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
3年前
已完结
Cell-penetrating peptides in oncologic pharmacotherapy: A review
3年前
已完结
Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancer
3年前
已完结
Cell-Penetrating Peptide Enhanced Antigen Presentation for Cancer Immunotherapy
3年前
已完结
Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
3年前
已完结
皖公网安备34019202002308
